Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case-Control Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

NCT05732987 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05732987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case-Control Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2023
Completion date
September 30, 2029
Enrollment
3,370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory dermatoses, neutrophil-mediated inflammatory dermatoses